LONDON–(BUSINESS WIRE)–#bigpharma–The pharmaceutical manufacturing industry is considered one of the top 10 industries with the highest barriers to entry. Issues such as high R&D costs, challenging regulatory approval processes, and intellectual property obstacles are making it increasingly difficult for new companies to enter this competitive market. Infiniti’s market entry analysis enables pharmaceutical manufacturing companies to identify, evaluate, and efficiently maneuver these barriers to entry. It also equips them to establish their brand and gain significant market share in a highly challenging market.
To leverage Infiniti’s expertise in offering market entry analysis, and successfully champion the pharmaceutical manufacturing industry, request a free proposal.
“With new and developing market growth drivers, the pharmaceutical manufacturing industry has become a highly competitive space and is attempting to recover from the disruptions caused by the COVID-19 pandemic. Currently, pipeline players are attempting to establish themselves in the recovering industry successfully. However, the pharma manufcaturing industry is considered among the top 10 industries with the highest barriers to entry,” says a pharmaceutical manufacturing industry expert at Infiniti Research.
The COVID-19 pandemic has taken a significant toll on the pharmaceutical manufacturing industry in recent months. However, with changing market dynamics, new trends, and highly impactful market growth drivers, the industry is on the path to recovery. Trends and growth drivers such as higher life expectancy, rising awareness about health and wellness, and high prevalence of chronic diseases are substantially propelling growth in the industry. The biggest challenge, however, continues to be the various barriers to entry in the pharmaceutical manufacturing industry. As the industry recovers, pipeline players are attempting to establish their brand in this highly competitive industry. To assist new companies in their attempts, Infiniti’s experts analyzed the market and identified four significant barriers to entry. In their recent article, the experts discuss the major barriers to entry and explain how market entry analysis can help companies efficiently establish themselves in the pharmaceutical manufacturing industry.
To further understand the impact of barriers to entry on new companies in the pharmaceutical manufacturing industry, request more information. (Read more…)
Infiniti’s experts identified the following four significant barriers to entry in the pharmaceutical manufacturing industry:
- Having a well-established distribution network, and appropriate infrastructure is crucial and challenging for newer companies, giving established companies a substantial advantage
- Obtaining all prerequisite regulatory approvals before marketing or distributing a new drug is a long-drawn and extremely expensive, particularly for new companies
- Starting a pharmaceutical manufacturing company requires large investments in infrastructure, and R&D, with the possibility of not earning revenue for over a decade.
- Patents serve as a legal and strategic safeguard for established companies and help them stop new companies from entering the market without a completely new pharmaceutical drug.
- Gain in-depth insights into the four significant barriers to entry in the pharmaceutical manufacturing industry by reading the complete article here.
About Infiniti Research
Established in 2003, Infiniti Research is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies. To know more, visit: https://www.infinitiresearch.com/about-us
Contacts
Infiniti Research
Anirban Choudhury
Marketing Manager
US: +1 844 778 0600
UK: +44 203 893 3400
https://www.infinitiresearch.com/contact-us